interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Deferiprone

Generic competition · all medicines · read 12 November 2026

Is there a generic of Deferiprone, and who makes it?

Deferiprone appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 3 generic makers listed as marketed across them. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came 7.3 years after the first brand approval. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Deferiprone2 dosage-form groups in the Orange Book
3generic makers listed
  1. Deferiprone appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 3 generic makers listed as marketed across them.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Where both are dated, the first generic approval came 7.3 years after the first brand approval.
  4. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Tablet, Oral

One to three generic makers listed

Brand listed as marketed: Ferriprox. 3 generic makers with 6 generic products listed as marketed; the first generic approval is dated 8 February 2019.

201020152020202520302035204003brand 2011Taro Pharmaceutical Industries Ltd, first approval 8 February 2019Hikma Pharmaceuticals Usa Inc, first approval 29 March 2021Pharmazone, first approval 11 December 2025data datePatent 11723874 listed to expire 25 October 2038Patent 11357731 listed to expire 25 October 2038Patent 10940115 listed to expire 25 October 2038Patent 10780055 listed to expire 25 October 2038Patent 11458103 listed to expire 25 October 2038Patent 10940116 listed to expire 25 October 2038Exclusivity ODE-417 to 30 April 2028Exclusivity ODE-420 to 30 April 2028Exclusivity ODE-421 to 30 April 2028
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end
Generic maker (applicant)First approvalProducts
Taro Pharmaceutical Industries Ltd8 February 20192
Hikma Pharmaceuticals Usa Inc29 March 20212
Pharmazone11 December 20252

Patents and exclusivities still listed

  • 30 April 2028Exclusivity ODE-417 Ferriprox
  • 30 April 2028Exclusivity ODE-420 Ferriprox
  • 30 April 2028Exclusivity ODE-421 Ferriprox
  • 25 October 2038Patent 11723874
  • 25 October 2038Patent 11357731
  • 25 October 2038Patent 10940115 drug product
  • 25 October 2038Patent 10780055 drug product
  • 25 October 2038Patent 11458103 drug product
  • 25 October 2038Patent 10940116 drug product

Solution, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Ferriprox. No generic is listed as marketed.

201520202025203001brand 2015data datePatent 8703156 listed to expire 26 October 2029Exclusivity ODE-417 to 30 April 2028Exclusivity ODE-418 to 30 April 2028Exclusivity ODE-419 to 30 April 2028
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 30 April 2028Exclusivity ODE-417 Ferriprox
  • 30 April 2028Exclusivity ODE-418 Ferriprox
  • 30 April 2028Exclusivity ODE-419 Ferriprox
  • 26 October 2029Patent 8703156 drug product

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.